IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$372.23 USD
+7.40 (2.03%)
Updated May 20, 2022 04:00 PM ET
4-Sell of 5 4
C Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
IDXX 372.23 +7.40(2.03%)
Will IDXX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that nearly triples the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IDXX
IDEXX (IDXX) Q1 Earnings Surpass Estimates, Margins Down
Idexx Laboratories (IDXX) Q1 Earnings Beat Estimates
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Earnings Preview: Idexx Laboratories (IDXX) Q1 Earnings Expected to Decline
Other News for IDXX
IDEXX Laboratories Inc. stock outperforms market on strong trading day
Heska price target raised to $155 from $150 at Alliance Global
IDEXX Laboratories Inc. stock outperforms market on strong trading day
IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
Top Buys From The Best Money Managers (Q1 2022)